Instil Bio Inc.

TIL | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.03

-$0.06 (-0.85%)

Sep 21, 2026, 11:53 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.85%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $47.68M

1D Range

6.95 7.09

52W Range

5.67 21.98

Valuation (TTM)

PE -1.59

PB 0.45

EV/EBITDA 0.72

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target $35

Cash Flow

FCF Yield -49.1%

SBC Adj. FCF Yield -60.3%

SBC Impact -22.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 58.4% | 1.4%

FCF 3Y | 5Y 39.3% | 52.8%

Returns

ROA -15.3%

ROE -26.8%

ROIC -18.6%

Financial Health

Net Cash

$67.84M

Current Ratio 21.67

Interest Coverage -6.59

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in ...

Sector Healthcare

Industry Biotechnology

Employees 17

IPO Date Mar 18, 2021

Website instilbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Upside

+28.02%

Buy (0)

Hold (3)

Sell (0)

Analyst Details ➞